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October 9, 2012:1430–7cultures (14%) reported in the literature (11), either a bias in
atient recruitment or in the selection of follow-up duration
hould also be taken into account. Therefore, microbiological,
chocardiographic, and treatment information is essential to
larify the reason for the false-negative cases at 18F-FDG-PET/
CT, particularly for high pre-test likelihood. None of the
diagnostic techniques available represent by themselves the
“magic” tool: the application of patients’ tailored strategies
starting from the multidisciplinary comprehensive interpreta-
tion of clinical history and complete clinical characterization to
identify the most suitable diagnostic test rather then the use of
the single best test will be the strategy to increase the diagnostic
accuracy, therefore impacting patients’ management.
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ahead of print].Clinical Utility of 18F-FDG
ositron Emission Tomography
nd Computed Tomography in
atients With Suspected
ardiovascular Implantable
lectronic Device Infection
Sarrazin et al. (1) highlighted the usefulness of positron emission
tomography (PET)/computed tomography (CT) in patients with
suspected cardiovascular implantable electronic device infection
(CIED). The following points should be considered before reach-
ing a final conclusion.
1. Guidelines recommend avoiding fluorodeoxyglucose (FDG)-
PET scans when blood glucose level is 200 mg% in patients
with cancer because hyperglycemia compromises the diagnostic
ability by decreasing FDG uptake (2,3). Did the authors make
an attempt to study the impact of hyperglycemia on the
sensitivity and specificity of the scan because hyperglycemia is
common in patients with CIED infection?
2. In the study by Sarrazin et al. (1), how many patients received
antibiotic therapy before the scan and for how long of a
duration? What was the impact of prior antibiotic therapy on
the sensitivity and specificity of the scan?
3. Increased FDG uptake is nonspecific and may be increased in
the setting of inflammation, infection, malignancy, or clot
formation, whereas it may be decreased in patients with
leukopenia even in the presence of infection (4,5).
4. What is the impact of the scan results on patient management?
This question remains unanswered because the decision to treat
was not based on scan findings. Larger-scale prospective studies
with longer follow-up periods (to rule out any latent infection)
are required before supporting a conservative approach for
negative scans in patients with bacteremia.
Considering high scan cost, FDG-PET/CT should only be
used as an adjunct diagnostic test in selective patients with CIED
in whom routine workup of fever (including transesophageal
echocardiography) remains inconclusive.
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Reply
We thank Dr. Erba and colleagues as well as Dr. Sharma for their
interest in our paper (1). In the letter from Dr. Erba and colleagues,
they suggested different rates of false-positive and false-negative
results with 18F-fluorodeoxyglucose (FDG) positron emission
omography (PET)/computed tomography (CT). We agree that
iagnosis of device infection should not be limited to a single test.
onventional testing, clinical judgment, and practice according to
uidelines remain critical. However, our published data and
dditional personal experience using this technology showed that
he addition of PET/CT could be of great value in difficult cases.
t is common to use a group of patients with higher disease
revalence to demonstrate a proof of concept. Tests were also
erformed in 2 lower-risk control groups with recent device surgery or
o active infection. We are aware that Ploux et al. (2) had FDG
ptake on leads in 7.5% of controls; however, no information is
vailable on recent antibiotic use, whether attenuation-corrected
r noncorrected images were used, and follow-up duration
ecause this observation could be related to early signs of
nfection. The negative predictive value of PET/CT is useful, as
emonstrated in our study of 10 patients having an excellent
volution with no late recurrence following conservative treat-
ent at 15 months. Further studies are required to better
nderstand causes for false-positive and false-negative results.
ur study was not powered to examine the sensitivity/specificity
f PET/CT with different micro-organisms. Head-to-head com-
arison between 99mTc–hexamethylpropyleneamine oxime–
leukocyte single-photon emission CT/CT and 18F-FDG
PET/CT could be useful. There was no bias in patient recruitmentbecause all patients were recruited consecutively. All patients were
followed up until the end of the study. In conclusion, we do not
believe that PET/CT is a “magic” test, but it should now be
considered as an additional tool for decision making.
In response to the second letter by Dr. Sharma, our study was
not intended to evaluate the impact of hyperglycemia on PET/CT.
Patients with blood glucose 8 mmol/l (144 mg/dl) received
intravenous rapid-acting insulin 1 h prior to FDG injection. All
patients underwent PET/CT within 48 h of initiation of antibiotic
therapy. However, we agree that prior antibiotic therapy could
have an impact on test results. False-positive results can occur with
Dacron pouches, inflammation, or hematoma, but FDG uptake is
usually higher with infection. We agree that further studies with
longer follow-up are required. We do not believe that PET/CT
should be used in all cases, but it appears useful in patients with
cardiac device and fever of unknown origin, as well as in patients
for which knowledge of the extent of infection could change the
decision to perform device and lead extraction.
*Jean-François Sarrazin, MD
François Philippon, MD
Jean Guimond, MD
Michel Tessier, MD
Mikaël Trottier, MD
*Institut Universitaire de Cardiologie et
Pneumologie de Québec
2725, chemin Sainte-Foy
Québec, QC, G1V 4G5
Canada
E-mail: jean-francois.sarrazin@criucpq.ulaval.ca
http://dx.doi.org/10.1016/j.jacc.2012.06.029
EFERENCES
1. Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18
positron emission tomography/computed tomography for identification
of cardiovascular implantable electronic device infections. J Am Coll
Cardiol 2012;59:1616–25.
2. Ploux S, Riviere A, Amaroui S, et al. Positron emission tomography in
patients with suspected pacing system infections may play a critical role
in difficult cases. Heart Rhythm 2011;8:1478–81.
